Edesa Biotech Inc.

NASDAQ: EDSA · Real-Time Price · USD
2.24
-0.02 (-0.88%)
At close: Aug 15, 2025, 3:59 PM
2.23
-0.22%
After-hours: Aug 15, 2025, 04:04 PM EDT

Edesa Biotech Income Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Revenue
n/a n/a n/a n/a -1.12M -1.12M -1.12M n/a 1.12M 1.12M 1.12M n/a -3.51M -3.51M -3.51M -3.51M 500.00 110.48K 221K
Cost of Revenue
93.41K 119.03K 139.92K 141.84K 187.81K 219.4K 201.3K 183.47K 166.46K 113.06K 115.63K 118.19K 118.16K 119.77K 119.7K 89.94K 63.32K 33.59K 13.82K
Gross Profit
-93.41K -119.03K -139.92K -141.84K -1.31M -1.34M -1.32M -183.47K 951.64K 1.01M 1M -118.19K -3.63M -3.63M -3.63M -3.6M -62.82K 76.89K 207.18K
Operating Income
-6.45M -6.47M -7.06M -7.01M -8.38M -8.51M -8.7M -9.22M -9.69M -13.42M -15.59M -18.37M -21.02M -21.29M -26.23M -23.68M -20.21M -15.9M -7.91M
Interest Income
18.99K 51.27K 94.2K 153.5K 208.95K 258.86K 301.38K 289.85K 254.04K 188.8K 106.83K 63.52K 34.27K 19.36K 16.36K 11.16K 5.29K 6.48K 24.51K
Pretax Income
-5.92M -5.84M -6.11M -6.17M -6.93M -7.24M -7.72M -8.37M -9.47M -13.27M -15.5M -17.55M -18.42M -17.39M -15.08M -13.34M -11.67M -8.68M -7.91M
Net Income
-5.92M -5.84M -6.11M -6.17M -6.93M -7.25M -7.72M -8.33M -9.4M -13.19M -15.42M -17.51M -18.4M -17.39M -15.08M -13.34M -11.67M -8.68M -7.91M
Selling & General & Admin
3.9M 3.97M 3.81M 4.04M 4.56M 4.56M 4.52M 4.43M 4.05M 4.27M 4.85M 5.04M 5.35M 5.71M 5.71M 5.73M 5.23M 4.36M 3.94M
Research & Development
2.55M 2.51M 3.2M 2.88M 3.73M 3.86M 4.14M 4.79M 5.64M 9.16M 10.74M 13.34M 15.67M 15.59M 20.52M 17.95M 14.97M 11.65M 4.18M
Other Expenses
n/a n/a 14.77K 14.77K -28.72K -28.72K -43.49K n/a 43.49K 43.49K 43.49K n/a -80.78K -80.78K n/a n/a 80.78K 80.78K n/a
Operating Expenses
6.45M 6.47M 7.01M 6.92M 7.71M 7.84M 8.08M 8.64M 9.69M 13.42M 15.59M 17.59M 18.38M 17.34M 15.11M 13.34M 11.73M 8.84M 8.12M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a -45.4K -90.43K -90.43K -90.43K -45.03K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
6.45M 6.47M 7.06M 7.01M 7.8M 7.93M 8.12M 8.64M 9.69M 13.42M 15.59M 17.59M 18.38M 17.34M 15.11M 13.34M 11.73M 8.84M 8.13M
Income Tax Expense
800.00 800.00 800.00 800.00 800.00 800.00 800.00 -42.69K -65.09K -82.61K -82.61K -41.91K -20.31K -9.06K -9.06K 17.54K 17.54K 21.14K 17.69K
Shares Outstanding (Basic)
7.02M 5.31M 3.35M 3.2M 3.22M 3.19M 3.13M 3.03M 2.93M 2.85M 2.63M 2.29M 2.21M 1.98M 1.91M 1.9M 1.89M 1.66M 1.47M
Shares Outstanding (Diluted)
7.02M 5.31M 3.35M 3.2M 3.22M 3.19M 3.13M 3.03M 2.93M 2.85M 2.63M 2.29M 2.21M 1.98M 1.91M 1.9M 1.89M 1.66M 1.47M
EPS (Basic)
-1.33 -1.6 -1.88 -1.94 -2.21 -2.37 -2.61 -2.94 -3.59 -5.52 -7.01 -8.44 -9.17 -9.07 -8.12 -7.62 -7.18 -6.07 -5.9
EPS (Diluted)
-1.33 -1.6 -1.88 -1.94 -2.21 -2.37 -2.61 -2.94 -3.59 -5.52 -7.01 -8.44 -9.16 -9.06 -8.11 -7.61 -7.18 -6.07 -5.9
EBITDA
-5.83M -5.75M -5.92M -5.98M -6.73M -7.1M -7.66M -8.38M -9.5M -13.29M -15.45M -17.45M -18.32M -17.28M -14.96M -13.2M -11.52M -8.54M -7.82M
EBIT
-5.89M -5.84M -6.16M -6.28M -7.04M -7.44M -7.93M -8.57M -9.69M -13.42M -15.59M -17.59M -18.37M -17.33M -15.02M -13.25M -11.64M -8.65M -7.91M
Depreciation & Amortization
137.61K 163.24K 184.13K 186.05K 187.81K 219.4K 201.3K 183.47K 166.46K 113.06K 115.63K 118.19K 118.16K 119.77K 119.7K 118.79K 118.87K 111.16K 84K